NCT06691451View on ClinicalTrials.gov

Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission

Not yet recruitingOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Inflammatory Bowel Diseases
All Listed Sponsors
collaborator

Assiut University

OTHER

lead

Asmaa mohammed abdelaal abdelaal

OTHER

NCT06691451 - Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission | Biotech Hunter | Biotech Hunter